Moderna (MRNA) PT Raised to $95 at BofA Securities
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Price: $107.97 +1.69%
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 22 | Down: 21 | New: 11
Rating Summary:
11 Buy, 13 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 22 | Down: 21 | New: 11
Join SI Premium – FREE
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $95.00 (from $70.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Comments on Moderna (MRNA) Collaboration with OpenAI
- Hanwha Chemical Corp (009830:KS) PT Lowered to KRW27,000 at HSBC
- Dr. Martens Plc (DOCS:LN) PT Lowered to GBP0.70 at HSBC
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
